Publication Name	World Journal of Gastroenterology
Manuscript ID	4819
Country	China

Received	2013-07-25 10:16
Peer-Review Started	2013-07-25 15:46
To Make the First Decision	2013-08-21 18:28
Return for Revision	2013-08-23 09:42
Revised	2013-09-08 19:38
Second Decision	2013-09-29 10:22
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-09-29 22:13
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-11-02 19:58
Typeset the Manuscript	2013-11-26 10:25
Publish the Manuscript Online	2013-12-18 10:39

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Autobiography
Article Title	Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study
Manuscript Source	Invited Manuscript
All Author List	Lei Li, Wei Liu, Yu-Han Chen, Chun-Lei Fan, Pei-Ling Dong, Fei-Li Wei, Bing Li, De-Xi Chen and Hui-Guo Ding
Funding Agency and Grant Number	Funding Agency Grant Number Major Projects on Infectious Disease 2012ZX10002-008-005 Beijing Science and Technology Commission Research Projects H010210110129 Beijing Science and Technology Commission Research Projects Z111107058811067 High-level Talent Academic Leader Training Program 2011-2-19
Corresponding Author	Hui-Guo Ding, MD, PhD, Director, Department of Gastroenterology and Hepatology, Beijing You'an Hospital Affiliated with Capital Medical University, Fengtai district, Beijing 100069, China. dinghuiguo@medmail.com.cn
Key Words	Hepatitis B; Decompensated cirrhosis; Nucleos(t)ide analogues; Hepatocellular carcinoma; Drug resistance
Core Tip	This study was performed to analyse the clinical data of 312 patients with decompensated hepatitis B cirrhosis in a prospective cohort. These data showed that complete virological response could improve the clinical outcome in decompensated hepatitis B cirrhotic patients. However, clinicians should be aware of the high risk of hepatocellular carcinoma and liver failure in antiviral drug-resistant patients.
Publish Date	2013-12-18 10:39
Citation	Li L, Liu W, Chen YH, Fan CL, Dong PL, Wei FL, Li B, Chen DX, Ding HG. Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study. World J Gastroenterol 2013; 19(45): 8373-8381
URL	http://www.wjgnet.com/1007-9327/full/v19/i45/8373.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i45.8373

Full Article (PDF)	WJG-19-8373.pdf
Manuscript File	4819-Review.doc
Answering Reviewers	4819-Answering Reviewers.pdf
Copyright License Agreement	4819-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	4819-Language certificate.pdf
Peer-review Report	4819-Peer review(s).pdf
Scientific Editor Work List	4819-Scientific editor work list.doc